Company
BridgeBio Oncology Therapeutics, Inc.
BBOT · CIK 0001869105
Disposition (code F) of 1,047 shares at $3.94 per share.
Reporting Person Ben Yong · Officer Title Chief Med & Dev Officer · Transaction Code F
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001193125-26-414123 · filed 2026-10-05 · View filing →
Disposition (code F) of 1,047 shares at $3.94 per share.
Reporting Person Beltran Pedro · Officer Title President and CEO · Transaction Code F
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001193125-26-414127 · filed 2026-10-05 · View filing →
Disposition (code F) of 343 shares at $3.94 per share.
Reporting Person Elmelech Idan · Officer Title COO & Principal Financial Ofcr · Transaction Code F
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001193125-26-414131 · filed 2026-10-05 · View filing →
Disposition (code F) of 126 shares at $3.94 per share.
Reporting Person Cobo Marc · Officer Title Principal Accounting Officer · Transaction Code F
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001193125-26-414135 · filed 2026-10-05 · View filing →
Acquisition (code A) of 9,038 shares at $0 per share.
Reporting Person Cobo Marc · Officer Title Principal Accounting Officer · Transaction Code A
Traded Sep 10, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001193125-26-390624 · filed 2026-09-14 · View filing →
Disposition (code F) of 203 shares at $5.52 per share.
Reporting Person Cobo Marc · Officer Title Principal Accounting Officer · Transaction Code F
Traded Sep 10, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001193125-26-390624 · filed 2026-09-14 · View filing →